Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

New Vircell COVID-19 spike quantitative VirClia® IgG monotest

Products are for professional/laboratory use only.  We are happy to announce the launch of the new VirClia® monotest to detect and quantify IgG antibodies against SARS-CoV-2 Spike in human serum or plasma, with strong correlation to neutralizing antibodies.


  • SARS-CoV-2 Spike protein antigen.
  • Quantitative assay in IU/ml for detection of IgG antibodies according to First WHO International Standard for anti-SARS-CoV-2 immunoglobulin NIBSC code: 20/136. Quantification range up to 1,000 IU/ml.
  • Excellent clinical sensitivity and specificity.
  • Strong correlation with neutralization assay
  • Compatible with the broadest infectious disease CLIA monotest panel in the market.

 


Find out more about the VirClia Lotus instrument

View Blog Post >

Find out more about VirClia IgG monotest

View Flyer >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article